Aurobindo Pharma News
Pharma stocks see 3rd straight month of gains in August, Mankind Pharma and 6 others rise up to 23%
Pharma stocks continued their bullish trend in August, with the Nifty Pharma index rising by 6.61%, driven by strong performances from Mankind Pharma and others. The index has gained 36% this year, benefiting from increased US sales, new product launches, and strong quarterly earnings.
3 min read2 Sep 2024Stocks to buy: Lupin, KIMS, Aurobindo Pharma among pharma stock picks by Axis Securities
Stocks to buy: Pharma sector saw 11% YoY and 4% QoQ revenue growth in Q1FY25, driven by domestic market strength, new product launches, cost optimization, and US business expansion, according to Axis Securities. Aurobindo Pharma, Krishna Institute of Medical Sciences, and Lupin are top picks.
2 min read23 Aug 2024Nifty Pharma index surges 2% led by Natco Pharma, Glenmark Pharma, IPCA Laboratories
The Nifty Pharma Index increased by more than 2% on Friday’s session, driven by gains in stocks including Natco Pharma, Glenmark Pharmaceuticals, and IPCA Laboratories Ltd.
3 min read16 Feb 2024Nifty Pharma hits all-time high; 10 stocks including Lupin, Cipla, Glenmark Pharma, Divi’s Labs touch one-year peaks
In today’s trade, Lupin’s shares soared nearly 7%, hitting a new all-time high of ₹1,404 apiece after Japanese brokerage firm Nomura raised the target price on the stock to ₹1,593 apiece from the previous ₹1,290, maintaining its ’buy’ recommendation.
2 min read2 Jan 2024Buy or sell: Vaishali Parekh recommends three stocks to buy today — December 29
Buy or sell stocks: Vaishali Parekh has recommended three stocks to buy today — UBL, Berger Paints and Aurobindo Pharma
2 min read29 Dec 2023Aurobindo Pharma Q2 FY24 results: profit rise by 84.93% YOY
Aurobindo Pharma Q2 FY24 results: Revenue increased by 25.79% YoY & profit increased by 84.93% YoY
1 min read12 Nov 2023Cipla, Sun Pharma among top pharma picks for Motilal Oswal as US sales to help boost growth
Motilal Oswal upgrades Cipla’s rating to ’Buy’, while Dr Reddy’s, Zydus Lifesciences, Lupin, Aurobindo Pharma, and Torrent Pharma maintain their ratings. Sun Pharma retains ’Buy’ rating.
3 min read20 Sep 2023Aurobindo shares double on US show
The turnaround in the company’s prospects has been aided by an improved outlook for its US formulations business, which contributes almost half of the company’s overall revenues.
2 min read15 Aug 2023Q1 results today: Aurobindo Pharma, RVNL to Finolex Cables — 81 companies to declare Q1 results 2023
Q1 results today: 81 companies include Aurobindo Pharma, Rail Vikas Nigam Limited or RVNL, Finolex Cables, Amara Raja Batteries, Suprajit Engineering, Sindhu Trade Links, Kirloskar Industries, Landmark Cars, Siyaram Silk Mills, etc
2 min read12 Aug 2023Aurobindo Pharma share price falls as US FDA uncovers fresh faults at Anakapalli facility
US Food and Drug Administration officials found multiple faults at a plant run by Aurobindo Pharma as the watchdog continues to unearth wide-ranging lapses across the country’s factories while working through a pandemic-era inspection backlog.
1 min read30 Jun 2023Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared